Essential insights into Vietnam’s in-vitro diagnostics market

Vietnam’s IVD market, estimated at US$419.2m, faced a significant decline in 2022 from the previous year’s market size. This is caused by a decrease in point-of-care (POC) and molecular diagnostics (MDx) segments and fewer rapid antigen tests as pandemic restrictions were lifted.

Clearstate’s latest infographic highlights essential facts and trends in the country’s in-vitro diagnostics market.